Actavis Malta

  • We are the New Actavis. A Global Leader in Generics. NYSE : ACT.We are the New Actavis. A Global Leader in Generics. NYSE : ACT.

    ACT: An Emerging Leader in Specialty Pharmaceuticals

  • We are the New Actavis. A Global Leader in Generics. NYSE : ACT.We are the New Actavis. A Global Leader in Generics. NYSE : ACT.

    A Generics Leader in 60+ Global Markets

  • We are the New Actavis. A Global Leader in Generics. NYSE : ACT.We are the New Actavis. A Global Leader in Generics. NYSE : ACT.

    A Specialty Brands Leader in Women’s Health

  • We are the New Actavis. A Global Leader in Generics. NYSE : ACT.We are the New Actavis. A Global Leader in Generics. NYSE : ACT.

    Expanding Specialty Brands into Key Global Markets

  • We are the New Actavis. A Global Leader in Generics. NYSE : ACT.We are the New Actavis. A Global Leader in Generics. NYSE : ACT.

    Accelerating a Foundation in Biosimilars

Actavis plc (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has global headquarters in Dublin, Ireland and Administrative Headquarters in Parsippany, New Jersey, USA. Operating as Actavis Pharma, the Company develops, manufactures and markets generic, branded generic, legacy brands and Over-the-Counter (OTC) products in more than 60 countries.

Actavis Malta, has highly trained and dedicated employees, a favourable patent environment and state-of-the-art manufacturing facilities, making Malta a key contributor to the Actavis group of companies.

News

News Archive

Featured Products

Beacita is an anti-obesity medicine which contains Orlistat.Beacita 60mg

It is indicated for weight loss in adults (>18 years) who are overweight (Body Mass Index BMI > 28kg/m2) and it should be taken together with a low calorie, low fat diet and high exercise plan.

Beacita is a medicinal product available in pharmacies.

More information

Actavis Malta